Literature DB >> 25078264

Transcriptional down-regulation of epidermal growth factor (EGF) receptors by nerve growth factor (NGF) in PC12 cells.

Gadi Cohen1, Keren Ettinger, Shimon Lecht, Peter I Lelkes, Philip Lazarovici.   

Abstract

Nerve growth factor (NGF) treatment causes a profound down-regulation of epidermal growth factor (EGF) receptors (EGFR) during the neuronal differentiation of PC12 cells. This process was characterized by a progressive decrease in EGFR level, as measured by (125)I-EGF binding and Scatchard analysis, tyrosine phosphorylation, Western blotting, and bio-imaging using EGF-labeled with a near-infrared probe. Differentiation of the cells with NGF for 5-7 days produces a 95 % reduction in the amount of (35)S-methionine-labeled EGFR. This down-regulation does not occur in PC12-nnr5 cells, which lack the TrkA NGF receptor but is reconstituted in these cells upon their stable transfection with TrkA. The process of NGF-induced EGFR down-regulation was inhibited by K252a, a TrkA antagonist and by anti-TrkA antibodies but not by Thx-B, a blocker of the interaction of NGF with p75(NTR) receptors. NGF-induced (heterologous) down-regulation, but not EGF-induced (homologous) down-regulation of EGFR, was blocked in Ras-deficient PC12 cells. NGF treatment for 5-7 days of PC12 cells, grown in suspension or in 3D collagen gels, induces down-regulation of EGFR independent of neurite outgrowth. The messenger RNA (mRNA) for EGFR decreased in a comparable fashion. This process was correlated temporally with a decrease in the transcription of the EGFR gene. Treatment with NGF also increased the cellular content of GCF2, a putative inhibitory transcription factor of the EGFR gene. The temporal increase in GCF2, like the decrease in the EGFR mRNA, was not seen in TrkA deficient PC12 cells nor in cells expressing dominant-negative Ras. The results suggest that NGF-induced down-regulation of the EGFR is under transcriptional control, is TrkA and Ras-dependent, may involve transcriptional repression by GCF2, and independent of mechanisms that lead to NGF-induced neurite outgrowth in PC12cells. This heterologous down-regulation of EGFR would appear to be an efficient mean of desensitizing the neuron to proliferative stimuli, thereby representing a safety latch for initiating and sustaining NGF-induced neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25078264     DOI: 10.1007/s12031-014-0388-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  87 in total

Review 1.  Functional brain development in humans.

Authors:  M H Johnson
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

2.  EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells.

Authors:  Fiona Doetsch; Leopoldo Petreanu; Isabelle Caille; Jose Manuel Garcia-Verdugo; Arturo Alvarez-Buylla
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

Review 3.  A review of insulin/insulin-like peptide in the central nervous system.

Authors:  S U Devaskar
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

Review 4.  Drug interactions among the epidermal growth factor receptor inhibitors, other biologics and cytotoxic agents.

Authors:  Michele Visentin; Paola Biason; Giuseppe Toffoli
Journal:  Pharmacol Ther       Date:  2010-06-11       Impact factor: 12.310

5.  Down-modulation of EGF receptors in cells transformed by the src oncogene.

Authors:  W J Wasilenko; L K Shawver; M J Weber
Journal:  J Cell Physiol       Date:  1987-06       Impact factor: 6.384

6.  Norepinephrine decreases EGF binding in primary rat hepatocyte cultures.

Authors:  J L Cruise; S Cotecchia; G Michalopoulos
Journal:  J Cell Physiol       Date:  1986-04       Impact factor: 6.384

7.  Expression and chromosomal localization of the gene for the human transcriptional repressor GCF.

Authors:  A C Johnson; R Kageyama; N C Popescu; I Pastan
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

8.  Expression of a Trk high affinity nerve growth factor receptor in the human prostate.

Authors:  B R Pflug; C Dionne; D R Kaplan; J Lynch; D Djakiew
Journal:  Endocrinology       Date:  1995-01       Impact factor: 4.736

9.  Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture.

Authors:  B B Olwin; S D Hauschka
Journal:  J Cell Biol       Date:  1988-08       Impact factor: 10.539

10.  Differential and synergistic actions of nerve growth factor and cyclic AMP in PC12 cells.

Authors:  P W Gunning; G E Landreth; M A Bothwell; E M Shooter
Journal:  J Cell Biol       Date:  1981-05       Impact factor: 10.539

View more
  2 in total

1.  RNA Sequencing of Peripheral Blood Revealed that the Neurotropic TRK Receptor Signaling Pathway Shows Apparent Correlation in Recovery Following Spinal Cord Injury at Small Cohort.

Authors:  Chunqing Wang; Hangzhou Lv; Qing Li; Ke Gong; Lei Luo Yang; Zean Wei; Yujie Pan; Mingyong Wang
Journal:  J Mol Neurosci       Date:  2019-04-16       Impact factor: 3.444

Review 2.  Vitamin D and Its Potential Interplay With Pain Signaling Pathways.

Authors:  Abdella M Habib; Karim Nagi; Nagendra Babu Thillaiappan; VijayaKumar Sukumaran; Saghir Akhtar
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.